Home » Technology » Wondermed pulls $4,600K out of a hole to ply you with ketamine – TechCrunch

Wondermed pulls $4,600K out of a hole to ply you with ketamine – TechCrunch

Wondermed pulls ,600K out of a hole to ply you with ketamine – TechCrunch

For those of us who’ve been a little bit wobbly on the mental health front over the past couple of years, there are a bunch of options starting to crop up. The on-demand chat-based therapy options are one, and at-home ketamine-assisted treatments are another. We’ve seen Mindbloom and Fieldtrip Health taking pole position, and recently, Wondermed announced it raised $4.6 million to join the ketamine-powered bandwagon.

The services are all minor variations on a very similar theme. You sign up and give them some money, and are taken through a telemedicine protocol to figure out whether ketamine is a reasonable treatment option for you. If yes, a small parcel turns up at the door, and you’re invited, with various degrees of supervision, to drop in, disassociate, and face your inner demons.

I write light-heartedly about this, but ketamine treatment completely changed my life, for reasons that I’m not entirely comfortable writing about in a place where everyone can read it. Suffice it to say; I’m a little suspicious of how ‘easy’ it is to get approved for at-home Ketamine treatment — my experience with Mindbloom reminded me of the early days of the medical marijuana process, where you’d essentially have to try pretty hard not to be approved — but the mental health breakthroughs I experienced in the treatments are undeniable.

See also  Women Aren't the Only People Who Get Abortions

Wonder Sciences is joining the rapidly filling market with its Wondermed product, and what it calls “the most accessible ketamine solution on the market,” which, as far as I can tell, is mostly based on price. It claims it is available at an introductory rate of $249 per month. Mindbloom is slightly more expensive ($1,000 or so for the first 3 months, which works out to around $333 per month. For…

Read full article on techcrunch.com